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Aim. Chronic gastritis was assessed serologically, endoscopically and histologically to identify correlations between these methods.
Methods. Subjects comprised 319 patients who had provided informed consent. Serological assessment of chronic gastritis was
based on the pepsinogen test method. Endoscopic gastritis and histological gastritis were assessed and scored according to the
Kimura-Takemoto classiﬁcation system and the updated Sydney classiﬁcation system respectively, and correlations between these
three methods were studied. Results. Pepsinogen I/II ratio showed a signiﬁcant correlation to the extent of mononuclear cell
inﬁltration of the gastric corpus. When histological gastritis was divided, on the basis of the distribution of mononuclear cell
inﬁltration, into gastritis limited to the antrum and corpus gastritis, these types were distinguished with high accuracy using a
pepsinogen I/II ratio of 3 as the cutoﬀ. A good correlation was also seen between pepsinogen I/II ratio and development of atrophy
in endoscopic gastritis, where groups with and without advanced atrophy were also distinguished with high accuracy using a
cutoﬀ value of 3. Conclusion. Signiﬁcant correlations exist between serum pepsinogen levels, endoscopic gastritis, and histological
gastritis. Pepsinogen I/II ratio allows prediction of the existence of endoscopic gastritis and histological gastritis, or the extent of
their development, with high accuracy.
1.Introduction
Measurements of the serum levels of pepsinogens (PGs)
are widely used to screen for gastric cancer [1, 2]. PG is
immunologically classiﬁable as PG I or PG II, where PG I is
primarily secreted into the gastric lumen by the chief cells
of the fundic glands and PG II is secreted by the cardiac
glands, pyloric glands, and duodenal glands in addition to
the fundic glands. PG is present, although in minute levels,
in the blood. Measurements of the serum levels of PG I or
the ratio of PG I to PG II are well-known nonendoscopic
tools for diagnosing atrophic gastritis [3–5]. Samloﬀ et al.
reported that atrophic gastritis can be diagnosed on the basis
of decreases in serum PG I level and PG I/II ratio [6]. This
is referred to as “serologic biopsy”. In a chromoendoscopic
studyusingCongored,Mikietal.reportedahighcorrelation
in stepwise decreases in serum PG I level and PG I/II
ratio to increases in the atrophic gland border associated
with gastric mucosal atrophy [3]. Several reports have also
described correlations between histological gastritis and2 Gastroenterology Research and Practice
serum PG levels [7–10], but the available data describing
variations in serum PGs with histopathological features
of gastritis are limited and somewhat controversial. In
children undergoing endoscopy and antral biopsy, a positive
correlation has been reported between serum PG I values
and the severity of antral inﬂammatory cell inﬁltration [7].
However, amongst healthy adult volunteers with gastritis,
no correlation between serum PGs and antral inﬂammation
was observed, though signiﬁcant correlation with corpus
inﬂammation scores was seen [8]. Knight et al. reported that
levels of serum PG I decreased with progression from an
antral predominant pattern, through pangastritis to a corpus
predominant pattern of gastritis [9].
Chronic gastritis can be assessed serologically, endoscop-
ically, and histologically, and these methods are widely used
in clinical settings. However, detailed, multifaceted studies
of the correlations and points of correspondence between
these methods have yet to be undertaken. Multifaceted
understanding to chronic gastritis is far from comprehen-
sive. Therefore, we aimed to examine correlations between
serological diagnosis based on serum PG levels, endoscopic
diagnosis of gastritis based on the Kimura-Takemoto clas-
siﬁcation system [11], and histological diagnosis of gastritis
based on the updated Sydney classiﬁcation system [12].
2. Methods
Subjects comprised 319 patients who had been examined
for epigastric symptoms at Matsushita Memorial Hospital
betweenApril2006andMarch2007.Thestudywasapproved
by the Ethics Committee of Matsushita Memorial Hospital,
and each patient gave written informed consent. Patients
who were taking oral acid-inhibiting drugs (H2 receptor
antagonists or proton pump inhibitors), who had previously
undergone Helicobacter pylori (Hp) eradication therapy,
or who had a history of gastric surgery were excluded.
Blood samples were taken while patients were fasting, serum
PG levels were determined by Chemiluminescent enzyme
immunoassay, and serum Hp antibody titer was determined
by enzyme immunoassay (E Plate; Eiken, Tokyo, Japan).
Endoscopy was performed by an endoscopist in the
Department of Gastroenterology at Matsushita Memorial
Hospital. Endoscopic gastric mucosal atrophy was classiﬁed
according to the Kimura-Takemoto classiﬁcation system,
using the following scores: absence of any atrophy, 0
point; closed-type gastritis, 1 point; open-type gastritis,
2 points. Diagnosis was made by the endoscopist who
performed an examination and the ﬁrst author, and any
diﬀerences in opinion were resolved by consensus. For
histological assessment of gastritis, biopsies were taken from
two locations comprising the antral greater curvature and
the greater curvature of the gastric corpus during endoscopy,
and specimens were diagnostically analyzed by two pathol-
ogists at Matsushita Memorial Hospital. Prior to diagnostic
analysis, the pathologists held a discussion using a schema
of the parameters (mononuclear cells, neutrophils, atrophy,
Hp, intestinal metaplasia (IM)) of the updated Sydney
classiﬁcation system and agreed on a grading procedure. In
Table 1: Clinical characteristics of patients.
Age (years) 56.5 (12–94)
Sex: male/female 200/119
Hp seropositive (%) 69.0 (220/319)
Endoscopic ﬁndings
Normal 11
Atrophic gastritis 258
Gastric ulcer 53
Duodenal ulcer 39
Erosive gastritis 17
Gastric cancer 39
Serum pepsinogens
Pepsinogen I 71.99
(38.65–80.90)∗
Pepsinogen II 22.37
(11.48–26.63)∗
Pepsinogen I/II ratio 3.55 (2.20–4.70)∗
Kimura-Takemoto classiﬁcation
Absence of any atrophy 60
Closed-type gastritis 146
Open-type gastritis 113
∗Variables are presented as median (interquartile range) for skewes vari-
ables.
this study, grades of normal, mild, moderate, and marked
ﬁndings were given scores of 0, 1, 2, or 3 point, respectively.
Statistical analysis involved the use of SPSS version 11
(SPSS, Chicago, ILL, USA) to compare≥3 groups using
analysis of variance (ANOVA) and to compare pairs by
the Fisher Protected Least Signiﬁcant Diﬀerence test. The
relationship between two variables was represented using the
Pearson correlation coeﬃcient.
3. Results
PatientcharacteristicsaregiveninTable 1.Meanagewas56.5
years (range, 12–94 years), and serum Hp antibody-positive
rate was 69.0% (220/319).
Results for the parameters in this study are as follows.
3.1. Correlation between Serum PG Levels and Histological
Gastritis. Analysis of the correlation between serum PG I
and II levels and PG I/II ratio to histological parameter
scores based on the updated Sydney classiﬁcation system
revealed that PG I/II ratio showed a stronger correlation
to histological ﬁndings than did serum PG I or II levels
(not shown). Table 2 shows the correlation between PG I/II
ratio and histological parameters by gastric location (antrum
and corpus), revealing a signiﬁcant (P<0.05) correlation
between all parameters and PG I/II ratio. This included
signiﬁcant correlations to mononuclear cell inﬁltration and
neutrophil inﬁltration of the gastric corpus (r =− 0.389
and r =− 0.442, resp.). The correlation coeﬃcient of
mononuclear cell inﬁltration of corpus (r =− 0.442) was
stronger than that of another.Gastroenterology Research and Practice 3
Table 2: Pepsinogen I/II ratio in relation to histopathology scores.
rP
Mono
Antrum −0.309 < 0.0001
Corpus −0.389 < 0.0001
Neutro
Antrum −0.256 0.0007
Corpus −0.442 <0.0001
Atrophy
Antrum −0.222 0.0044
Corpus −0.293 0.0001
Hp
Antrum −0.174 0.022
Corpus −0.291 <0.0001
IM
Antrum −0.218 0.004
Corpus −0.211 0.0054
Mono = mononuclear cells.
Neutro: neutrophils.
Hp: Helicobacter pylori.
IM: intestinal metaplasia.
Next, histological gastritis was classiﬁed into four groups
based on the extent of mononuclear cell inﬁltration in
the antrum and gastric corpus (Table 3): normal or mild
gastritis (N); antrum-predominant gastritis (A); corpus-
predominant gastritis (C); pangastritis (P). Serum Hp
antibody-positive rates for each group were 37.1%, 84.4%,
78.3%, and 86.7%, respectively. Comparison of PG I/II ratio
between these four groups revealed that, compared to the N
group, PG I/II ratio was signiﬁcantly lower in the other three
groups (Figure 1). Histological gastritis was divided into “no
gastritis” (N group) and “gastritis” (A, C, and P groups), and
receiver operating characteristic (ROC) analysis of gastritis
diagnosis by PG I/II ratio revealed an optimal PG I/II ratio
cutoﬀ of 4.0 for a diagnosis of histological gastritis, with
82.6% sensitivity and 82.9% (Figure 2(a)). Upon subsequent
division into “two groups without corpus gastritis” (N and
A groups) and “two groups with corpus gastritis” (C and
P groups), ROC analysis of the diagnostic capability by PG
I/II ratio revealed an optimal PG I/II ratio cutoﬀ of 3.2 for
the diagnosis of corpus gastritis, with 73.6% sensitivity and
74.6% speciﬁcity (Figure 2(b)).
3.2. Correlation between Serum PG Levels and Endoscopic
Gastric Mucosal Atrophy. Examination of serum PG levels
and endoscopic gastric mucosal atrophy revealed serum
PG I levels were signiﬁcantly lower in open-type gastritis
comparedto the closed-type. PG I/II ratio also decreased sig-
niﬁcantly as endoscopic gastric mucosal atrophy progressed.
No signiﬁcant diﬀerences in serum PG II levels were seen
between groups (Figure 3).
Endoscopic gastric mucosal atrophy was divided into a
“group without atrophy” and “groups with atrophy” (closed
or open type), and ROC analysis of the diagnostic capability
Table 3: Classiﬁcation of histological gastritis based on mononu-
clear cell inﬁltration.
Corpus Degree of
mononuclear cells
Antrum degree of mononuclear cells
0o r1
(absent or mild)
2o r3
(moderate or severe)
0o r1 N A
(absent or mild) (37.1%) (84.4%)
2o r3 C P
(moderate or severe) (78.3%) (86.7%)
N: normal or mild gastritis (serum Hp antibody-positive rate).
A: antrum predominant gastritis.
C: corpus predominant gastritis.
P: pangastritis.
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Figure 1: Correlation between serum pepsinogen I/II ratio and
topography of gastritis determined by the extent of mononuclear
cell inﬁltration: PG I/II ratio was signiﬁcantly lower in A, C,
and P group than in N group. N: normal or mild gastritis; A:
antrum-predominant gastritis; C: corpus-predominant gastritis; P:
pangastritis: horizontal bar, median; box: 25th–75th interquartile
range: vertical lines: range of values.
by PG I/II ratio revealed an optimal PG I/II ratio cut-oﬀ
of 3.9 for distinguishing between presence and absence of
endoscopic gastric mucosal atrophy, with 68.0% sensitiv-
ity and 66.0% speciﬁcity (Figure 4(a)). Upon subsequent
endoscopic division into“groupswithoutadvancedatrophy”
(no gastric mucosal atrophy, closed type) and a “group
with advanced atrophy” (open type), ROC analysis of the
diagnostic capability by PG I/II ratio revealed an optimal
PG I/II ratio cut-oﬀ of 2.9 for distinguishing between
the presence or absence of advanced atrophy, with 67.9%
sensitivity and 70.4% speciﬁcity (Figure 4(b)).
3.3. Correlation between Endoscopic Gastric Mucosal Atrophy
and Histological Gastritis. Analysis of endoscopic gastric
mucosal atrophy scores and the Sydney classiﬁcation-based
histological parameter scores by site revealed a signiﬁcant
correlation between endoscopic gastric mucosal atrophy
scores and scores for mononuclear cell inﬁltration of the4 Gastroenterology Research and Practice
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Figure 2: Receiver operator characteristic analysis in the diagnostic capability of histological gastritis by serum pepsinogen I/II ratio. (a)
Discrimination of normal or mild gastritis (N Group) from other patterns of gastritis (A, C and P Group). (b) Discrimination of without-
corpus gastritis (N and A Group) from with corpus gastritis (C and P Group).
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Figure 3: Correlations between serum pepsinogen levels and topography of gastric mucosal atrophy determined by endoscopy. PG I/II
ratio decreased signiﬁcantly as endoscopic gastric mucosal atrophy progressed. Horizontal bar: median; box: 25th–75th interquartile range;
vertical lines: range of values; NS: not signiﬁcant.
gastric corpus (r = 0.459) (Table 4; Figure 5). Other
parameters, including neutrophil inﬁltration of the gastric
corpus (r = 0.382), mucosal atrophy of the gastric corpus
(r = 0.390), and intestinal metaplasia of the antrum
(r = 0.348), showed signiﬁcant but weak correlations to
endoscopic gastric mucosal atrophy.
4. Discussion
The concept of chronic gastritis has long been used in
the absence of strict deﬁnitions, resulting in confusion in
the clinical setting. However, with the advent of Hp in
the 1980’s, chronic gastritis has come to be regarded as a
condition in which atrophy progresses with repeated loss
and regeneration of the gastric mucosa due to chronic
histological inﬂammation associated with persistent Hp
infection [13]. The Sydney system was created in an attempt
to more objectively assess chronic gastritis using a visual
scale based on the concept of infectious gastritis caused
by Hp infection [14, 15], and the updated version [12]i s
now being used internationally. Although histopathological
assessment is widely used in the Sydney system, endoscopicGastroenterology Research and Practice 5
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Figure 4: Receiver operator characteristic analysis in the diagnostic capability of endoscopic gastric mucosal atrophy by serum pepsinogen
I/II ratio. (a) Discrimination of with endoscopic ﬁndings of atrophy from without endoscopic ﬁndings of atrophy. (b) Discrimination of
without advanced atrophy from with advanced atrophy (open type).
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Figure 5: Correlation between scores for mononuclear cell inﬁl-
tration of the gastric corpus and topography of gastric mucosal
atrophy determined by endoscopy. There was a strong correlation
between endoscopic gastric mucosal atrophy scores and scores for
mononuclear cell inﬁltration of the gastric corpus.
classiﬁcations have not yet become widespread, whereas,
in Japan, the Kimura-Takemoto endoscopic classiﬁcation
system [11] for chronic gastritis, which focuses on atrophic
changes, is now also widely used.
In a study on correlations between chronic gastritis and
PG levels, Samloﬀ et al. [6] measured serum PG I and PG II
levels in 1982 and reported that atrophic gastritis could be
Table 4: Endoscopic gastric mucosal atrophy scores in relation to
histopathology scores.
rP
Mono
Antrum 0.184 0.0169
Corpus 0.459 <0.0001
Neutro
Antrum 0.036 0.6422
Corpus 0.382 <0.0001
Atrophy
Antrum 0.185 0.0195
Corpus 0.390 <0.0001
Hp
Antrum −0.06 0.4437
Corpus 0.156 0.0427
IM
Antrum 0.348 <0.0001
Corpus 0.196 0.0108
Mono = mononuclear cells.
Neutro = Neutrophils.
Hp =Helicobacter pylori.
IM = intestinal metaplasia.
diagnosed on the basis of decreased PG I levels and PG I/II
r a t i o .S e r u mP Gl e v e l sh a v ec o m et ob eu s e da ss e r o l o g i c a l
markers of atrophic gastritis. With the subsequent advent
of Hp and publication of the Sydney system, several reports
have been issued on the use of this histological assessment to6 Gastroenterology Research and Practice
PG I/II ratio Endoscopic gastritis Histological gastritis
Absence of mucosal atrophy    
Cut-off value of 4
Cut-off value of 3
Mucosal atrophy without advanced change
(closed type)
Gastritis limited to antrum
(A group) 
Mucosal atrophy with advanced change
(open type)
Gastritis advanced to corpus
(C group/P group)
Ng r o u p 


Figure 6: Correlation between endoscopic gastric mucosal atrophy and histological gastritis with PG I/II ratio. Setting the respective cut-oﬀ
values to about 4 and 3 appeared to have enabled estimation of the presence or absence of endoscopic atrophy and histological gastritis, or
the extent of their development.
study correlations between serum PG levels and histological
gastritis, and correlations with inﬂammation of the gastric
corpus [8] and atrophy of the gastric corpus [9]h a v eb e e n
identiﬁed.
Endoscopy is also prevalent in Japan, and numerous
reports have examined correlations between serum PG
levels and endoscopic gastritis. Miki et al. reported a high
correlation in stepwise decreases in serum PG I level and
PG I/II ratio to increases in the atrophic border associated
with endoscopic gastric mucosal atrophy [3]. A chromoen-
doscopic study using methylene blue also showed a high
correlation between intestinal metaplasia and serum PG
levels [16]. However, no detailed studies on correlations
between serum PG levels, endoscopic gastritis, and histolog-
ical gastritis have yet been reported.
This study ﬁrst examined whether any correlations
exist between serum PG levels and any of the histological
assessment parameters in the updated Sydney classiﬁcation,
revealing signiﬁcant correlations between PG I/II ratio and
neutrophil and mononuclear cell inﬁltrations of the gastric
corpus (r =− 0.442 and r =− 0.389, resp.). Correlations
between mononuclear cell inﬁltration and PG levels have
already been reported [8, 10]. We decided that scrutinizing
mononuclear cell inﬁltration as a parameter in assessing
chronic histological changes would be worthwhile, classiﬁed
histological gastritis based on the distribution pattern of
mononuclear cell inﬁltration in the gastric mucosa, and
analyzed the correlation to serum PG levels. Results of ROC
analysis revealed that progression of histological gastritis as
deﬁned by the distribution of mononuclear cell inﬁltration
can be predicted relatively well using serum PG I/II ratio.
The optimal PG I/II ratio cutoﬀ for distinguishing between
absence of histological gastritis (N group) and presence of
histological gastritis (A, C, and P groups) was 4.0, and
the optimal cutoﬀ for distinguishing between normal or
histological gastritis limited to the antrum (N and A groups)
and histological gastritis that had progressed to the corpus
(C and P groups) was 3.2.
Examination of the correlation between PG levels and
endoscopic gastric mucosal atrophy based on the Kimura-
TakemotoclassiﬁcationrevealedanoptimalPGI/IIratiocut-
oﬀ of 3.9 for distinguishing between absence of endoscopic
gastric mucosal atrophy and presence of gastric mucosal
atrophy(closedandopentypes),andanoptimalcutoﬀof2.9
for distinguishing between cases without advanced atrophy
(no gastric mucosal atrophy, closed type) and cases with
advanced atrophy (open type). These values are generally
consistent with the optimal cut-oﬀ values for distinguishing
between absence of histological gastritis and presence of
histological gastritis, and between normal or histological
gastritis limited to the antrum and histological gastritis
that has advanced to the corpus. Setting the respective
cut-oﬀ values to about 4 and 3 appeared to have enabled
estimation of the presence or absence of endoscopic atrophy
and histological gastritis or the extent of their development.
Based on the present analysis of the same population, PG
I/II ratio appears useful for predicting the extent to which
endoscopic gastritis and histological gastritis have advanced,
and, from the perspective of PG I/II ratio, histological
gastritis limited to the antrum (A group) and endoscopic
gastritis without advanced atrophic changes (closed type)
correspond to each other, as do histological gastritis that
has advanced to the gastric corpus (C group/P group)
and endoscopic gastritis with advanced atrophic changes
(open type) (Figure 6). These ﬁndings from this study could
contribute to shared understanding of chronic gastritis that
various doctors such as gastrointestinal endoscopist and
pathologist evaluated by three diﬀerent methods, that is,
endoscopy, microscopy, or PG test.
The Sydney system was proposed, and the description
and classiﬁcation of histological gastritis have become fairly
well established, whereas no international consensus has
yet been reached on the description and classiﬁcation of
endoscopic gastritis. Points of correspondence between his-
tological gastritis based on the updated Sydney classiﬁcation
and endoscopic gastritis based on the Kimura-TakemotoGastroenterology Research and Practice 7
classiﬁcation have also not been studied in great deal. The
present study of correlations between endoscopic gastritis
(Kimura-Takemoto classiﬁcation) and histological gastritis
(updated Sydney classiﬁcation), including serum PG levels,
in the same population showed strong correlations and
points of correspondence between the three systems. This
represents the ﬁrst attempt at a multifaceted look at chronic
gastritis from serological, endoscopic, and histological per-
spectives to ascertain correlations and points of correspon-
dence, and the results here may prove clinically useful in
contemplating chronic gastritis.
References
[1] F. Kitahara, K. Kobayashi, T. Sato, Y. Kojima, T. Araki, and
M. A. Fujino, “Accuracy of screening for gastric cancer using
serum pepsinogen concentrations,” Gut,v o l .4 4 ,n o .5 ,p p .
693–697, 1999.
[2] A. Kodoi, M. Yoshihara, K. Sumii, K. Haruma, and G.
Kajiyama, “Serum pepsinogen in screening for gastric cancer,”
Journal of Gastroenterology, vol. 30, no. 4, pp. 452–460, 1995.
[3] K. Miki, M. Ichinose, and A. Shimizu, “Serum pepsinogens as
a screening test of extensive chronic gastritis,” Gastroenterolo-
gia Japonica, vol. 22, no. 2, pp. 133–141, 1987.
[4] P. Malfertheiner, F. M´ egraud, C. O’Morain et al., “Cur-
rent concepts in the management of Helicobacter pylori
infection—the Maastricht 2–2000 consensus report,” Alimen-
tary Pharmacology and Therapeutics, vol. 16, no. 2, pp. 167–
180, 2002.
[ 5 ]K .B o r c h ,C .K .A x e l s s o n ,H .H a l g r e e n ,M .D a m k j a e rN i e l s e n ,
T. Ledin, and P. B. Szesci, “The ratio of pepsinogen A
to pepsinogen C: a sensitive test for atrophic gastritis,”
Scandinavian Journal of Gastroenterology,v o l .2 4 ,n o .7 ,p p .
870–876, 1989.
[6] I. M. Samloﬀ, K. Varis, and T. Ihamaki, “Relationships among
serumpepsinogenI,serumpepsinogenII,andgastricmucosal
histology. A study in relatives of patients with pernicious
anemia,” Gastroenterology, vol. 83, no. 1, part 2, pp. 204–209,
1982.
[7] G. Oderda, D. Vaira, D. Dell’Olio et al., “Serum pepsinogen I
and gastrin concentrations in children positive for Helicobac-
terpylori,”JournalofClinicalPathology,vol.43,no.9,pp.762–
765, 1990.
[8] J. Kreuning, J. Lindeman, I. Biemond, and C. B. Lamers,
“Serological parameters in assessment of degree of gastritis in
healthyvolunteers,”DigestiveDiseasesandSciences,vol.40,no.
3, pp. 609–614, 1995.
[9] T. Knight, J. Wyatt, A. Wilson et al., “Helicobacter pylori
gastritis and serum pepsinogen levels in a healthy population:
development of a biomarker strategy for gastric atrophy in
high-risk groups,” British Journal of Cancer, vol. 73, no. 6, pp.
819–824, 1996.
[10] K. Bodger, J. I. Wyatt, and R. V. Heatley, “Variation in serum
pepsinogens with severity and topography of Helicobac-
ter pylori-associated chronic gastritis in dyspeptic patients
referred for endoscopy,” Helicobacter, vol. 6, no. 3, pp. 216–
224, 2001.
[11] K. Kimura and T. Takemoto, “An endoscopic recognition of
the atrophic border and its signiﬁcance in chronic gastritis,”
Endoscopy, vol. 3, pp. 87–97, 1969.
[12] M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa,
“Classiﬁcation and grading of gastritis. The updated Sydney
system. International workshop on the histopathology of
gastritis, Houston 1994,” The American Journal of Surgical
Pathology, vol. 20, no. 10, pp. 1161–1181, 1996.
[13] E. J. Kuipers, A. M. Uyterlinde, A. S. Pena et al., “Long-term
sequelae of Helicobacter pylori gastritis,” Lancet, vol. 345, no.
8964, pp. 1525–1528, 1995.
[14] A. B. Price, “The Sydney system: histological division,” Journal
of Gastroenterology and Hepatology, vol. 6, no. 3, pp. 209–222,
1991.
[15] G. N. Tytgat, “The Sydney system: endoscopic division.
Endoscopic appearances in gastritis/duodenitis,” Journal of
Gastroenterology and Hepatology, vol. 6, no. 3, pp. 223–234,
1991.
[16] Y. Urita, K. Hike, N. Torii et al., “Serum pepsinogens as a
predicator of the topography of intestinal metaplasia in pa-
tients with atrophic gastritis,” Digestive Diseases and Sciences,
vol. 49, no. 5, pp. 795–801, 2004.